Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Solid Phase Microextraction | 2 | 2018 | 20 | 1.54 | Why? |
| Trabeculectomy | 4 | 2019 | 20 | 1.28 | Why? |
| Glaucoma Drainage Implants | 3 | 2019 | 12 | 1.11 | Why? |
| Mitomycin | 3 | 2018 | 27 | 1.07 | Why? |
| Ocular Hypotension | 2 | 2018 | 3 | 0.98 | Why? |
| Intraocular Pressure | 5 | 2019 | 276 | 0.97 | Why? |
| Glaucoma | 3 | 2019 | 225 | 0.80 | Why? |
| Liquid Phase Microextraction | 1 | 2018 | 4 | 0.79 | Why? |
| Anesthetics, General | 1 | 2019 | 12 | 0.79 | Why? |
| Oxazepam | 1 | 2018 | 1 | 0.77 | Why? |
| Prosthesis Implantation | 2 | 2019 | 261 | 0.74 | Why? |
| Diazepam | 1 | 2018 | 45 | 0.73 | Why? |
| Fibrin Tissue Adhesive | 1 | 2017 | 11 | 0.71 | Why? |
| Glaucoma, Open-Angle | 1 | 2018 | 55 | 0.71 | Why? |
| Nanocomposites | 1 | 2018 | 62 | 0.70 | Why? |
| Pterygium | 1 | 2017 | 14 | 0.70 | Why? |
| Photorefractive Keratectomy | 1 | 2017 | 12 | 0.70 | Why? |
| Zinc Oxide | 1 | 2018 | 69 | 0.70 | Why? |
| Nylons | 1 | 2017 | 34 | 0.69 | Why? |
| Silicon Dioxide | 1 | 2018 | 131 | 0.69 | Why? |
| Lasers, Excimer | 1 | 2017 | 37 | 0.68 | Why? |
| Sutures | 1 | 2017 | 57 | 0.68 | Why? |
| Endothelium, Corneal | 1 | 2017 | 41 | 0.67 | Why? |
| Refraction, Ocular | 1 | 2017 | 108 | 0.63 | Why? |
| Suture Techniques | 1 | 2017 | 138 | 0.60 | Why? |
| Visual Acuity | 4 | 2019 | 790 | 0.59 | Why? |
| Analgesics | 1 | 2019 | 451 | 0.56 | Why? |
| Liver Function Tests | 1 | 2021 | 1325 | 0.55 | Why? |
| Alkylating Agents | 3 | 2018 | 12 | 0.55 | Why? |
| Graphite | 1 | 2018 | 318 | 0.55 | Why? |
| Ophthalmologic Surgical Procedures | 1 | 2017 | 211 | 0.54 | Why? |
| Anesthesia, General | 1 | 2019 | 470 | 0.54 | Why? |
| Conjunctiva | 1 | 2017 | 620 | 0.44 | Why? |
| Pain | 1 | 2019 | 1084 | 0.43 | Why? |
| Pain Management | 1 | 2019 | 854 | 0.41 | Why? |
| Vascular Diseases | 1 | 2018 | 846 | 0.39 | Why? |
| Kidney Diseases | 1 | 2019 | 1434 | 0.34 | Why? |
| Reoperation | 2 | 2019 | 544 | 0.30 | Why? |
| Liver Diseases | 1 | 2021 | 2698 | 0.30 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.28 | Why? |
| Tonometry, Ocular | 3 | 2019 | 108 | 0.25 | Why? |
| Saliva | 1 | 2018 | 4679 | 0.23 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.21 | Why? |
| Febuxostat | 1 | 2020 | 29 | 0.21 | Why? |
| E-Selectin | 1 | 2008 | 55 | 0.19 | Why? |
| L-Selectin | 1 | 2008 | 42 | 0.19 | Why? |
| Eye Abnormalities | 1 | 2018 | 29 | 0.19 | Why? |
| Antimetabolites | 1 | 2019 | 106 | 0.19 | Why? |
| Valine | 1 | 2021 | 359 | 0.19 | Why? |
| Iran | 6 | 2021 | 5467 | 0.19 | Why? |
| Salts | 1 | 2018 | 44 | 0.19 | Why? |
| Sclera | 1 | 2017 | 31 | 0.18 | Why? |
| Aberrometry | 1 | 2017 | 7 | 0.18 | Why? |
| Optic Nerve | 1 | 2018 | 123 | 0.18 | Why? |
| Toxoplasmosis | 1 | 2018 | 59 | 0.17 | Why? |
| Autografts | 1 | 2017 | 78 | 0.17 | Why? |
| Cytomegalovirus Vaccines | 1 | 2017 | 6 | 0.17 | Why? |
| Glaucoma, Angle-Closure | 1 | 2018 | 46 | 0.17 | Why? |
| Corneal Topography | 1 | 2017 | 45 | 0.17 | Why? |
| Eyelids | 1 | 2017 | 40 | 0.17 | Why? |
| Adsorption | 1 | 2018 | 261 | 0.17 | Why? |
| Cell Size | 1 | 2017 | 106 | 0.17 | Why? |
| Carbamates | 1 | 2021 | 485 | 0.17 | Why? |
| Visual Fields | 1 | 2018 | 123 | 0.17 | Why? |
| Mucorales | 1 | 2018 | 92 | 0.17 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.16 | Why? |
| Pyrrolidines | 1 | 2021 | 558 | 0.16 | Why? |
| Surface Properties | 1 | 2018 | 448 | 0.16 | Why? |
| Ophthalmic Solutions | 1 | 2017 | 136 | 0.16 | Why? |
| Periodontitis | 1 | 2008 | 171 | 0.16 | Why? |
| Antigens, CD1d | 1 | 2015 | 12 | 0.15 | Why? |
| Sofosbuvir | 1 | 2021 | 518 | 0.15 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.15 | Why? |
| Congenital Abnormalities | 1 | 2017 | 170 | 0.15 | Why? |
| Surgical Flaps | 1 | 2017 | 188 | 0.15 | Why? |
| Imidazoles | 1 | 2021 | 631 | 0.15 | Why? |
| Alternative Splicing | 1 | 2015 | 82 | 0.15 | Why? |
| Peptic Ulcer | 1 | 2015 | 85 | 0.14 | Why? |
| Alanine Transaminase | 1 | 2021 | 1329 | 0.14 | Why? |
| Global Burden of Disease | 1 | 2018 | 531 | 0.14 | Why? |
| Melatonin | 1 | 2021 | 578 | 0.14 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.14 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.14 | Why? |
| Aspartate Aminotransferases | 1 | 2021 | 1394 | 0.14 | Why? |
| Protein Isoforms | 1 | 2015 | 347 | 0.13 | Why? |
| Follow-Up Studies | 5 | 2021 | 17020 | 0.13 | Why? |
| Receptor, ErbB-2 | 1 | 2015 | 267 | 0.13 | Why? |
| Accidents, Traffic | 1 | 2018 | 464 | 0.13 | Why? |
| Ambulatory Care | 2 | 2021 | 4947 | 0.13 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.12 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.12 | Why? |
| Treatment Outcome | 8 | 2021 | 51732 | 0.12 | Why? |
| Cancer Survivors | 1 | 2019 | 588 | 0.11 | Why? |
| Polymorphism, Genetic | 1 | 2008 | 1074 | 0.11 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.11 | Why? |
| Psychometrics | 1 | 2018 | 1269 | 0.10 | Why? |
| Thymol | 1 | 2009 | 5 | 0.10 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.10 | Why? |
| Humans | 31 | 2021 | 930598 | 0.10 | Why? |
| Lamiaceae | 1 | 2009 | 29 | 0.10 | Why? |
| Chemical Fractionation | 1 | 2009 | 89 | 0.10 | Why? |
| Stomach Neoplasms | 1 | 2015 | 477 | 0.10 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.10 | Why? |
| Monoterpenes | 1 | 2009 | 46 | 0.10 | Why? |
| Female | 21 | 2021 | 380317 | 0.09 | Why? |
| Male | 20 | 2021 | 367725 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Sleep | 1 | 2021 | 2695 | 0.09 | Why? |
| Mucormycosis | 1 | 2018 | 832 | 0.09 | Why? |
| Solvents | 1 | 2009 | 139 | 0.09 | Why? |
| Adult | 15 | 2021 | 244371 | 0.09 | Why? |
| Publishing | 1 | 2018 | 990 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Brain Neoplasms | 1 | 2015 | 669 | 0.09 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.09 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Liver | 1 | 2021 | 4007 | 0.08 | Why? |
| Sex Factors | 4 | 2020 | 11014 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.07 | Why? |
| Quality Control | 2 | 2018 | 628 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2020 | 88759 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2017 | 2517 | 0.07 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.06 | Why? |
| Survival Analysis | 3 | 2021 | 7592 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2019 | 3228 | 0.06 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.05 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Gingival Hemorrhage | 1 | 2008 | 2 | 0.05 | Why? |
| Periodontal Attachment Loss | 1 | 2008 | 3 | 0.05 | Why? |
| Aggressive Periodontitis | 1 | 2008 | 2 | 0.05 | Why? |
| Chronic Periodontitis | 1 | 2008 | 9 | 0.05 | Why? |
| Dental Plaque | 1 | 2008 | 13 | 0.05 | Why? |
| Periodontal Pocket | 1 | 2008 | 10 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2021 | 508 | 0.05 | Why? |
| Thymine | 1 | 2008 | 29 | 0.05 | Why? |
| Serine | 1 | 2008 | 90 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.05 | Why? |
| DNA, Ribosomal Spacer | 1 | 2018 | 49 | 0.05 | Why? |
| Rhizopus | 1 | 2018 | 32 | 0.05 | Why? |
| Fluorouracil | 1 | 2019 | 169 | 0.05 | Why? |
| Office Management | 1 | 2018 | 23 | 0.05 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.05 | Why? |
| Cytosine | 1 | 2008 | 92 | 0.04 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.04 | Why? |
| Phenylalanine | 1 | 2008 | 122 | 0.04 | Why? |
| Leucine | 1 | 2008 | 121 | 0.04 | Why? |
| Lung | 2 | 2021 | 31049 | 0.04 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.04 | Why? |
| Breast Neoplasms | 1 | 2015 | 3633 | 0.04 | Why? |
| Amphotericin B | 1 | 2018 | 256 | 0.04 | Why? |
| Depression | 1 | 2020 | 14116 | 0.04 | Why? |
| Chemotherapy, Adjuvant | 1 | 2019 | 606 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.04 | Why? |
| Arginine | 1 | 2008 | 377 | 0.04 | Why? |
| Adenine | 1 | 2008 | 463 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Paranasal Sinuses | 1 | 2018 | 217 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Dyspepsia | 1 | 2015 | 60 | 0.04 | Why? |
| Los Angeles | 1 | 2017 | 647 | 0.04 | Why? |
| Host-Pathogen Interactions | 2 | 2020 | 11041 | 0.04 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Case-Control Studies | 3 | 2019 | 17671 | 0.03 | Why? |
| Aging | 1 | 2020 | 3581 | 0.03 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.03 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.03 | Why? |
| Middle East | 1 | 2018 | 1418 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2018 | 711 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Alleles | 1 | 2008 | 1557 | 0.03 | Why? |
| Helicobacter Infections | 1 | 2015 | 216 | 0.03 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.03 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.03 | Why? |
| Helicobacter pylori | 1 | 2015 | 262 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Regression Analysis | 1 | 2019 | 2484 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| Exercise Test | 1 | 2018 | 911 | 0.03 | Why? |
| Vaccines, DNA | 1 | 2017 | 871 | 0.03 | Why? |
| Chromatography, Gas | 1 | 2009 | 25 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.02 | Why? |
| Blood Platelets | 1 | 2021 | 1704 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Mexico | 1 | 2018 | 2787 | 0.02 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Animals | 1 | 2019 | 78931 | 0.02 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.02 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.02 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.02 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.02 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.02 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Perception | 1 | 2018 | 2827 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Nurses | 1 | 2020 | 2285 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2008 | 4027 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Models, Statistical | 1 | 2019 | 5312 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2008 | 8495 | 0.01 | Why? |
| Multivariate Analysis | 1 | 2009 | 5440 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 13720 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Prognosis | 1 | 2015 | 32490 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
Alizadeh-Navaei's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(87)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_